[Retracted] The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma

Table 2

Univariate regression and multivariate survival model of OS in patients with glioma.

Characteristics	Total ()	Univariate analysis		Multivariate analysis
		Hazard ratio (95% CI)	value	Hazard ratio (95% CI)	value
WHO grade	634
G2	223
G3	243	2.999 (2.007-4.480)	<0.001	1.815 (1.077-3.061)	0.025
G4	168	18.615 (12.460-27.812)	<0.001	3.759 (0.961-14.706)	0.057
1p/19q codeletion	688
Codel	170
Noncodel	518	4.428 (2.885-6.799)	<0.001	1.244 (0.589-2.624)	0.567
Primary therapy outcome	259
SD	147
PD	112	2.288 (1.529-3.426)	<0.001	3.508 (2.049-6.006)	<0.001
SALL4	695
Low	348
High	347	1.900 (1.490-2.423)	<0.001	2.275 (1.425-3.633)	<0.001
IDH status	685
Mut	439
WT	246	8.551 (6.558-11.150)	<0.001	1.600 (0.814-3.145)	0.173
Age	695
>60	143
≤60	552	0.214 (0.165-0.278)	<0.001	0.247 (0.141-0.430)	<0.001
Histological type	695
Astrocytoma	195
Oligoastrocytoma	134	0.657 (0.419-1.031)	0.068	1.186 (0.660-2.129)	0.568
Oligodendroglioma	198	0.580 (0.395-0.853)	0.006	0.565 (0.304-1.051)	0.071
Glioblastoma	168	6.791 (4.932-9.352)	<0.001
Gender	695
Female	297
Male	398	1.262 (0.988-1.610)	0.062	1.583 (0.982-2.554)	0.060